title: [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
abstract: The optimal management of clinically localized (T1, T2) prostate cancer remains controversial. In response to these controversies the American Urological Association guidelines considered surgery, radiotherapy or watchful waiting to be options, because the literature does not provide clear evidence for the superiority of any one treatment. The aim of this paper is presentation of current knowledge regarding this problem.
authors.affiliation: Medical University of Wroclaw, Poland.
authors.forename: Jolanta
authors.initials: J
authors.lastname: Szelachowska
authors.forename: Jan
authors.initials: J
authors.lastname: Kornafel
authors.forename: Iwona
authors.initials: I
authors.lastname: Gisterek
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D019370:Observation; D017430:Prostate-Specific Antigen / Q000097:blood*; D011468:Prostatectomy / Q000379:methods; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D011788:Quality of Life; D016019:Survival Analysis
chemical_list: D006728:Hormones; D017430:Prostate-Specific Antigen